CTRI/2023/02/049928尚未招募4 期
Efficacy and safety profile of Netarsudil 0.02% in in primary angle closure disease : A randomised comparative study
Advanced Eye Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Primary angle closure spectrum of patients with Intraocular more than 21 mmHg will be randomised to receive both the drugs.
排除标准
- •one eyed patient, secondary glaucomas, open angle glaucoma, previous history of angle surgeries, previous history of trabecular meshwork lasers
研究者
相似试验
尚未招募
4 期
Efficacy and safety of Netarsudil in primary angle closure glaucoma.CTRI/2023/08/056186Maharaja agrasen medical college
已完成
3 期
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular HypertensionOpen Angle GlaucomaOcular HypertensionNCT03284853Aerie Pharmaceuticals436
进行中（未招募）
不适用
Efficacy and tolerability of nimesulide for the treatment of migraine attacks, a randomised, double blind, placebo controlled cross-over trialEUCTR2005-000583-28-ITHELSINN HEALTHCARE SA162
尚未招募
3 期
Comparison between two medicines Netarsudil and Latanoprost for raised pressure of eyesCTRI/2023/12/060534Dr Rinky Thakur
已完成
4 期
Effect of Netarsudil vs Brimonidine in NTG Patients on LatanoprostNormal Tension GlaucomaNCT06449352Westlake Eye Specialists100